Author: Ken Dropiewski

XableCath Receives Second FDA Clearance for Its Peripheral Arterial Catheters

SALT LAKE CITY–(BUSINESS WIRE)–XableCath, Inc., innovators of products designed to aid in the treatment of peripheral artery disease (PAD), announced that its second catheter, XableCath™ abrasion tip support catheter, was cleared by the FDA. The XableCath blunt tip catheter received FDA clearance at the end of 2017. This clearance gives […]

RenalGuard Solutions Announces Late Breaking Clinical Trial Data Accepted for Presentation at Heart Failure 2018

MILFORD, Mass.–(BUSINESS WIRE)–RenalGuard Solutions™, Inc., a medical device company focused on innovative fluid management technologies for the cardiac and vascular markets, today announced that new data from a clinical trial studying RenalGuard®-Guided Diuretic Therapy will be presented as a late breaking abstract at Heart Failure 2018, the annual meeting of […]

Initial Clinical Results of Konica Minolta Healthcare’s Dynamic Digital Radiography Presented at ATS 2018 Annual Meeting

WAYNE, N.J., May 24, 2018 (GLOBE NEWSWIRE) — Konica Minolta Healthcare Americas, Inc., announced that two clinical studies utilizing Dynamic Digital Radiography (DDR), the company’s innovative X-ray technology under development, were presented at the American Thoracic Society (ATS) 2018 Annual Meeting this week. Dynamic Digital Radiography is a new modality […]

Independent Stent Imaging Study Shows Excellent Healing Profile with Resolute Onyx DES in Complex Patients with Coronary Artery Disease

DUBLIN and PARIS- May 24, 2018 – Investigators today unveiled clinical data from the independently run Onyx 1-Month OCT Study, which showed strong early vessel healing in a patient population that contained a high percentage of patients with complex coronary artery disease who were implanted with the Resolute Onyx(TM) DES at […]

Zenosense, Inc.: MIDS Shareholder Update

VALENCIA, SPAIN, May 24, 2018 (GLOBE NEWSWIRE) — Zenosense, Inc. (OTC PINK: ZENO) (“Zenosense”, the “Company”), a healthcare technology company primarily focused on the development and commercialization of MIDS Cardiac™, a Point of Care handheld device for the early detection of certain cardiac event biomarkers.  We believe that MIDS Cardiac will […]

Positive Two-Year Data from MiStent® DESSOLVE III Trial Presented at EuroPCR

DURHAM, N.C., May 23, 2018 /PRNewswire/ — A 24-month update on the DESSOLVE III trial of the MiStent® Sirolimus Eluting Absorbable Polymer Coronary Stent System (MiStent) was presented this week at EuroPCR 2018, an international congress of interventional cardiovascular medicine researchers and clinicians held in Paris, France. Data were presented by William Wijns, M.D., Ph.D., […]

CeloNova Announces Positive Clinical Results of eCOBRA Study at EuroPCR 2018

SAN ANTONIO, May 23, 2018 /PRNewswire/ — CeloNova BioSciences, Inc. (CeloNova), a global medical device company that offers a family of innovative products based upon its proprietary Polyzene™-F nanocoating technology, today announced 1-year clinical trial results from the eCOBRA post-market study of the company’s COBRA PzF™ NanoCoated Coronary Stent (NCS) System. The clinical trial […]

PiCSO therapy reduces infarct size in STEMI patients.

AWANS, Belgium, May 24, 2018 /PRNewswire/ — Miracor Medical SA announced today the clinical results from the physician-sponsored OxAMI-PiCSO study were published in the EuroIntervention journal and presented at the Hotline session of the EuroPCR conference by Dr. Giovanni Luigi De Maria, MD, the Heart Centre, Oxford University Hospitals, Oxford, UK. The latest results, obtained with the PiCSO® Impulse System, contribute to the […]

QT Vascular Enters Into Asset Purchase And Option Agreement With Teleflex

SINGAPORE, May 24, 2018 /PRNewswire/ — QT Vascular Ltd., (“QT Vascular“, and with its subsidiaries, the “Company“), announced today that it has entered into an asset purchase and option agreement (the “APOA“) with Teleflex Life Sciences Unlimited Company and Teleflex Incorporated (“Teleflex“). Under the APOA, Teleflex will acquire the non-drug coated product line […]